Danaher Co. (NYSE:DHR) CFO Daniel L. Comas sold 36,000 shares of the stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $103.88, for a total transaction of $3,739,680.00. Following the completion of the sale, the chief financial officer now directly owns 124,218 shares of the company’s stock, valued at $12,903,765.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of NYSE DHR traded down $0.36 during mid-day trading on Friday, reaching $104.39. The company had a trading volume of 2,608,564 shares, compared to its average volume of 3,078,206. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. The firm has a market capitalization of $72.94 billion, a price-to-earnings ratio of 25.90, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04. Danaher Co. has a 12-month low of $91.65 and a 12-month high of $110.13.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The firm had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. On average, analysts predict that Danaher Co. will post 4.51 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.61%. Danaher’s dividend payout ratio is currently 15.88%.

A number of large investors have recently added to or reduced their stakes in the stock. Gardiner Nancy B grew its holdings in Danaher by 5.8% during the third quarter. Gardiner Nancy B now owns 9,110 shares of the conglomerate’s stock valued at $991,000 after purchasing an additional 500 shares during the last quarter. Reilly Financial Advisors LLC grew its holdings in Danaher by 62.6% during the third quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after purchasing an additional 501 shares during the last quarter. Securian Asset Management Inc grew its holdings in Danaher by 0.8% during the second quarter. Securian Asset Management Inc now owns 62,119 shares of the conglomerate’s stock valued at $6,130,000 after purchasing an additional 504 shares during the last quarter. Centaurus Financial Inc. grew its holdings in Danaher by 20.3% during the second quarter. Centaurus Financial Inc. now owns 3,026 shares of the conglomerate’s stock valued at $299,000 after purchasing an additional 510 shares during the last quarter. Finally, Whitnell & Co. grew its holdings in Danaher by 2.1% during the third quarter. Whitnell & Co. now owns 25,270 shares of the conglomerate’s stock valued at $2,746,000 after purchasing an additional 514 shares during the last quarter. Hedge funds and other institutional investors own 76.80% of the company’s stock.

A number of analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Bank of America set a $113.00 price target on shares of Danaher and gave the stock a “buy” rating in a research report on Thursday, July 19th. Robert W. Baird reduced their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research report on Friday, October 19th. Royal Bank of Canada increased their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Morgan Stanley increased their price target on shares of Danaher from $113.00 to $120.00 and gave the stock an “overweight” rating in a research report on Friday, July 13th. One equities research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $112.14.

TRADEMARK VIOLATION WARNING: “Danaher Co. (DHR) CFO Daniel L. Comas Sells 36,000 Shares of Stock” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2018/11/10/danaher-co-dhr-cfo-daniel-l-comas-sells-36000-shares-of-stock.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

See Also: What is a balanced fund?

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.